Manali PetrochemQ2 FY23

Manali Petrochem Q2 FY23 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹68.38P/E: 9.9Market Cap: ₹1.2K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 2

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • India business is growing, with Notedome products holding close to 45% market share in certain high-margin categories and aiming to expand further.
  • Penn Globe acquisition adds approximately GBP 16 million to top-line and is expected to sustain or improve EBITDA margins (~22%).
  • Specialty chemical contribution targeted to grow from current 6% to around 20%.
  • Indian agriculture and food segments expected to experience a CAGR of 12.3% over the next 5 years, driving demand for anti-foaming agents and related products.
  • Capacity utilization for Penn Globe is high (85-90%) with plans to explore expansion based on new large customers, especially in the US.
  • Manali Petrochemicals aims to expand PG (Propylene Glycol) production by 50,000 tons with Rs. 100 crore investment, projected to improve margins and volumes over 24 months post-clearances.
  • Overall growth focus remains on both Indian and overseas markets, leveraging strong market potential in specialty chemicals.

See what Manali Petrochem management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • No specific new fundraising through debt or equity is mentioned in the transcript.
  • Financing of the recent acquisition (Penn-White) was done entirely through Manali Petrochemicals Limited's (MPL) own funds.
  • Refinancing of the working capital facility will be done with a new asset base lending system.
  • Currently, MPL has no long-term debt on its books.
  • Cash utilization will be evaluated in the future for expansions and overseas investments before deciding on any shareholder rewards.
  • Focus remains on business growth and completing ongoing expansion projects before considering other financial actions.

See what Manali Petrochem management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Rs. 100 crores approved for Propylene Glycol (PG) expansion of 50,000 tons. (Page 15)
  • Focus on completing expansions in India with approvals in advanced stages; construction to start soon. (Page 14)
  • Some cash set aside for overseas investments with potential for further opportunities. (Page 14)
  • New subsidiary planned: Penn-White India Limited to manufacture specialty products domestically, leveraging lower costs and MPL's R&D. (Page 5)
  • Expansion plans dependent on securing large customers, especially in the US; current capacity utilization at 85-90%. (Page 7)
  • Emphasis on “Make in India” strategy to increase local manufacturing and reduce supply chain disruptions. (Page 9)
  • Sustainability initiatives include developing a new carbon dioxide-based process that may replace fossil fuel raw materials, enhancing margins and environmental benefits upon commercial success. (Pages 15-16)

Track Manali Petrochem — get its next earnings analysis in your feed

How does Manali Petrochem rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisManali Petrochem
Rev 3Mar 2

How does Manali Petrochem rank in Chemicals & Petrochemicals?

Compare Manali Petrochem against every Chemicals & Petrochemicals company (Q2 FY23) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What Manali Petrochem's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Neogen Chemicals Ltd (Q2 FY27)

    Consolidated: ₹295.96 crore (up from ₹208.66 crore in Q3 FY25) . Key results statement takeaways from Neogen Chemicals Ltd's Q2 FY27 results statement — and how

  • Mahickra Chemicals Ltd (Q2 FY27)

    682 million, a 34% year-on-year increase. Key results statement takeaways from Mahickra Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec

  • Vishnu Chemicals Ltd (Q2 FY27)

    2,837.7 lakhs increase (~7.07% growth YoY). Key results statement takeaways from Vishnu Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec

  • Yasons Chemex (Q2 FY27)

    4,927.35 lakhs for the same period in 2025, indicating a year-on-year decline of about 16.3% (Page 12). Key results statement takeaways from Yasons Chemex Care

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →